Elsevier

Journal of Ethnopharmacology

Volume 17, Issue 3, September 1986, Pages 277-282
Journal of Ethnopharmacology

Effect of Momordica charantia on the glucose tolerance in maturity onset diabetes

https://doi.org/10.1016/0378-8741(86)90116-9Get rights and content

Abstract

Investigations were carried out to evaluate the effect of Momordica charantia on the glucose tolerance of maturity onset diabetic patients. The fruit juice of M. charantia was found to significantly improve the glucose tolerance of 73% of the patients investigated while the other 27% failed to respond.

References (10)

  • M. Aslam et al.

    Interaction between curry ingredients and drug (Chlorpropamide)

    Lancet

    (1979)
  • E.H. Karunanayake et al.

    Oral hypoglycaemic activity of some medicinal plants of Sri Lanka

    Journal of Ethnopharmacology

    (1984)
  • M.S. Akhtar et al.

    Effect of Momordica charantia on blood glucose levels of normal and Alloxan diabetic rabbits

    Planta Medica

    (1981)
  • M.S. Akhtar

    Trial of Momordica charantia Linn, (karela) powder in patients with maturity onset diabetes

    Journal of the Pakistan Medical Association

    (1982)
  • V.S. Baldwa et al.

    Clinical trial with patients with Diabetes mellitus of an insulin like compound obtained from a plant source

    Uppsala Journal of Medical Science

    (1977)
There are more references available in the full text version of this article.

Cited by (191)

  • Plant Poisons, Hallucinogens, and Traditional Medicines

    2023, Manson's Tropical Diseases, Fourth Edition
  • Momordica charantia (bitter melon) modulates adipose tissue inflammasome gene expression and adipose-gut inflammatory cross talk in high-fat diet (HFD)-fed mice

    2019, Journal of Nutritional Biochemistry
    Citation Excerpt :

    Several animal studies have demonstrated the antiobesity, antidiabetic, antioxidant and anti-inflammatory properties of BM regardless of different varieties of BM, differences in the levels of BM dosages, duration of treatment, animal models as well as the formulation of HFD diet [24,26–29,31,56–58,127,128]. Encouraging preclinical studies further corroborate antidiabetic properties of BM in humans [26,31,129–131]. Since inflammasomes are critical mediators of inflammation during obesity and insulin resistance [11,15,19], our study is the first to indicate that antiobesity and antidiabetic effects of freeze-dried BM juice may be associated with its capacity to inhibit mRNA expression of components of inflammasome, several NOD receptors and their downstream signaling targets.

View all citing articles on Scopus
View full text